Adult

Dosing in obese patients

  • Obesity is defined as patients with a BMI over 30kg/m2.
  • Obesity is associated with changes in volume of distribution and clearance of some antibiotics.

Advice about the dosing of antibiotics in obese patients is given below. Early discussion with a pharmacist or infection specialist is advised.

Patients with renal and/or hepatic impairment are outside the scope of this document. Discussion with an antimicrobial pharmacist or infection specialist is strongly recommended.

Recommended changes to antibiotic dosing in obese patients

Drug class

Antibiotic

Dosing modification

Beta lactam

Penicillins

Use higher end of standard dose

Cephalosporins

Standard dosing

Carbapenems

Standard dosing

Meropenem preferred over ertapenem; in ITU patients consider prolonged (3hour) infusion

Quinolones

Ciprofloxacin

Consider using higher end of standard dose range

Levofloxacin / Moxifloxacin

Standard dosing

Lincosamides

Clindamycin

Standard dosing

Consider using higher dosages, especially for serious/life threatening infections

Glycopeptides

Vancomycin

Teicoplanin

Use Total body weight (TBW) to calculate dose

Aminoglycoside

Amikacin

Gentamicin

Tobramycin

Use Adjusted body weight (AdjBW) to calculate dose (This is standard in OUH calculator)

Other

Daptomycin

Use Total body weight (TBW) to calculate dose

Linezolid

Standard dosing

Colistimethate sodium 

Use (Ideal body weight) IBW to calculate dose

 

Metronidazole

Standard dosing

Common measures of weight

For obese patients, alternative measures of weight are sometimes used to modify antibiotic dosing.

Weight type

Definition

Used for

TBW: Total body weight

Patient’s true weight in kg

Vancomycin/Teicoplanin

Daptomycin

IBW: Ideal body weight

50kg (male) or 45kg (female) + 2.3kg for each inch over 5 feet

Colistimethate sodium

AdjBW: Adjusted body weight

IBW + 0.4(TBW – IBW)

Aminoglycosides

Therapeutic drug monitoring

Editorial Information

Last reviewed: 01 Sept 2023